Mirdametinib

Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK

Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

A Study of Mirdametinib in People With Central Nervous System Tumors

To Assess the Enzyme Inducing Effects of Carbamazepine on the PK of Mirdametinib in Healthy Participants

A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations

Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).

Efficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade Glioma

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors

Mirdametinib in Patients With Advanced NF1-mutant Melanoma

Mirdametinib in Histiocytic Disorders

A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer